Abstract:Introduction Influenza A virus (IAV) infection predisposes to subsequent bacterial superinfection in the lungs that promotes a greater pneumonia severity. Among host innate immune players, alveolar macrophages (AM) are essential for lung protection against bacteria. From mice studies, the prominent paradigm suggests that influenza infection induces almost total mouse AM (mAM) depletion, resulting in an increased vulnerability to secondary bacterial infection. Nevertheless, the potential IAV-induced AM depletion as never been study in human. The aim of the study is to characterize the AM number in newly influenza-infected human and to compare the ability of IAV to infect AM from mouse and human origin. Methods Because the observation of AM depletion in mice was described with non-translational influenza inoculum (too high), we infected c57BL/6J mice with a mild inoculum of influenza A virus (H3N2, 10 PFU) by intranasal route and measured the AM count. Next, we described a case report of a hospital-acquired influenza infection in a patient with pre and post-infection bronchoalveolar lavage (BAL) procedures. Then, we extracted data from 2 published clinical investigations assessing BAL in critical care unit and we performed an ancillary study included patients with a PCR-confirmed influenza infection and a BAL performed within the four firth days of ICU admission (AM expressed in mean ± SEM). Finally, using ex vivo AMs models, we compared the ability of IAV to infect mouse and human AMs and the subsequence consequences regarding inflammatory mediator production. Results Using mice model of mild IAV infection, we demonstrated that despite the low IAV inoculum the AM count dropped drastically in the BAL fluid from the fourth day (reduction of 64% from baseline) and was maximal at the seventh day post-infection (reduction of 90%). At the contrary, a patient newly infected by IAV (4 days after the onset of the symptoms) did not present significant modification of the AM count (> 200,000 cells/mL before and after the IAV infection). Next, we assessed the cellularity of BAL of influenza-infected critically ill patients ( n = 15) and controls ( n = 7), thanks to the ancillary study described. The absolute AM count was respectively 3.8 × 10 5 ± 1.5 × 10 5 cells/mL in influenza-infected and 2.8 × 10 5 ± 0.6 × 10 5 cells/mL in controls. In ex vivo AM models, we demonstrated that IAV infects, replicates, and induces inflammatory response similarly in AM of mouse and human origins. Conclusion We demonstrated that IAV-induced AM depletion in mouse but not in human. We did not observe difference in vitro regarding the viral replication and subsequent inflammatory response in mAM and mAM. It is unlikely that the secondary bacterial infections are explained by AM depletion in influenza-infected human.

Monitoring the Cascade of Monocyte-Derived Macrophages to Influenza Virus Infection in Human Alveolus Chips

Personal and familial substance misuse patterns among eating disordered and depressed subjects.

Simian Human Immunodeficiency Virus-Associated Pneumonia Correlates with Increased Expression of MCP-1, CXCL10, and Viral RNA in the Lungs of Rhesus Macaques

Proteome Alterations in Primary Human Alveolar Macrophages in Response to Influenza A Virus Infection.

The deadly dance of alveolar macrophages and influenza virus

Bacterial Colonization Dampens Influenza-Mediated Acute Lung Injury Via Induction of M2 Alveolar Macrophages

Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis

Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium During Influenza Infection

Spatiotemporal landscape of SARS-CoV-2 pulmonary infection reveals Slamf9+Spp1+ macrophages promoting viral clearance and inflammation resolution

Progress in Alveolar Macrophages

Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain

Extracellular Vesicle-Derived Mir-1249–5P Regulates Influenza A Virus-Induced Acute Lung Injury in RAW246.7 Cells Through Targeting SLC4A1

Biomimetic Alveolus-on-a-Chip for SARS-CoV-2 Infection Recapitulation

Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection

RNA-Seq Analysis of Influenza A Virus-Induced Transcriptional Changes in Mice Lung and Its Possible Implications for the Virus Pathogenicity in Mice

Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip

Influenza induces depletion of alveolar macrophages in mice but not in human

Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells

A human disease model of SARS-CoV-2-induced lung injury and immune responses with a microengineered organ chip